Features of hepatic and skeletal muscle insulin resistance unique to type 1 diabetes (scientific article published on 22 February 2012)

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

Q27861088

Cellular mechanisms of insulin resistance

Q29619549

Insulin is a stronger inducer of insulin resistance than hyperglycemia in mice with type 1 diabetes mellitus (T1DM).

Q30434577

Insulin resistance and cardiovascular disease

Q34011027

Glucose clamp technique: a method for quantifying insulin secretion and resistance

Q34191986

Insulin resistance, defective insulin-mediated fatty acid suppression, and coronary artery calcification in subjects with and without type 1 diabetes: The CACTI study

Q34448739

Effects of insulin on peripheral and splanchnic glucose metabolism in noninsulin-dependent (type II) diabetes mellitus

Q34541876

Insulin resistance in type 1 diabetes

Q34733637

Molecular understanding of hyperglycemia's adverse effects for diabetic complications

Q35005662

Are oxidative stress-activated signaling pathways mediators of insulin resistance and beta-cell dysfunction?

Q35034481

Diagnosis of fatty liver disease: is biopsy necessary?

Q35110258

Uptake and release of glucose by the human kidney. Postabsorptive rates and responses to epinephrine

Q35766893

Insulin signal transduction in human skeletal muscle: identifying the defects in Type II diabetes

Q36078595

Protein kinase C function in muscle, liver, and beta-cells and its therapeutic implications for type 2 diabetes

Q36756469

Banting Lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus

Q37141727

In skeletal muscle advanced glycation end products (AGEs) inhibit insulin action and induce the formation of multimolecular complexes including the receptor for AGEs.

Q37142827

Mechanism of impaired insulin-stimulated muscle glucose metabolism in subjects with insulin-dependent diabetes mellitus

Q37366705

Insulin resistance in skeletal muscles of patients with diabetes mellitus

Q38679694

Deficiencies of cardiovascular risk prediction models for type 1 diabetes

Q40302948

Can clinical factors estimate insulin resistance in type 1 diabetes?

Q40759534

Diabetes and cardiovascular disease. The Framingham study

Q41509493

Site of insulin resistance in type 1 diabetes: insulin-mediated glucose disposal in vivo in relation to insulin binding and action in adipocytes in vitro

Q42458341

Effect of type 1 diabetes on the gender difference in coronary artery calcification: a role for insulin resistance? The Coronary Artery Calcification in Type 1 Diabetes (CACTI) Study

Q43435231

Insulin resistance, intramyocellular lipid content, and plasma adiponectin in patients with type 1 diabetes

Q44559076

Intensive versus conventional glucose control in critically ill patients

Q46076336

Comparison of methods for achieving 24-hour energy balance in a whole-room indirect calorimeter

Q47834620

Impaired insulin stimulation of muscular ATP production in patients with type 1 diabetes.

Q51382819

Effects of fasting on insulin action and glucose kinetics in lean and obese men and women.

Q51466282

Efficacy of pulsatile versus continuous insulin administration on hepatic glucose production and glucose utilization in type I diabetic humans.

Q51633153

Natural course of insulin resistance in type I diabetes.

Q51633221

Hepatic and peripheral insulin resistance: a common feature of type 2 (non-insulin-dependent) and type 1 (insulin-dependent) diabetes mellitus.

Q51649670

Calculation of substrate oxidation rates in vivo from gaseous exchange.

Q52703700

Both acute and chronic near-normoglycaemia are required to improve insulin resistance in type 1 (insulin-dependent) diabetes mellitus.

Q54243448

Localization of rate-limiting defect for glucose disposal in skeletal muscle of insulin-resistant type I diabetic patients.

Q54331721

Defect in insulin action on expression of the muscle/adipose tissue glucose transporter gene in skeletal muscle of type 1 diabetic patients

Q68034011

Alterations in glucose metabolism during menstrual cycle in women with IDDM

Q68074221

Mechanisms of hyperglycemia-induced insulin resistance in whole body and skeletal muscle of type I diabetic patients

Q68100661

Estimation of endogenous glucose production during hyperinsulinemic-euglycemic glucose clamps. Comparison of unlabeled and labeled exogenous glucose infusates

Q68161753

Insulin resistance is a prominent feature of insulin-dependent diabetes

Q71477121

Regular exercise enhances insulin activation of IRS-1-associated PI3-kinase in human skeletal muscle

Diabetic retinopathy

issue

language of work or name

English

Q1860

P921

main subject

type-1 diabetes

Q124407

insulin resistance

Q1053470

P304

page(s)

1663-1672

P577

publication date

2012-02-22

P1433

published in

The Journal of Clinical Endocrinology and Metabolism

Q3186902

P1476

title

Features of hepatic and skeletal muscle insulin resistance unique to type 1 diabetes

P478

volume

Reverse relations

cites work (P2860)

Q35916487	Adiponectin-SOGA Dissociation in Type 1 Diabetes.
Q90286903	Advances in stable isotope tracer methodology part 1: hepatic metabolism via isotopomer analysis and postprandial lipolysis modeling
Q64947889	Carbohydrate Restriction in Type 1 Diabetes: A Realistic Therapy for Improved Glycaemic Control and Athletic Performance?
Q35077618	De novo lipogenesis and cholesterol synthesis in humans with long-standing type 1 diabetes are comparable to non-diabetic individuals
Q35004291	Delayed skeletal muscle mitochondrial ADP recovery in youth with type 1 diabetes relates to muscle insulin resistance
Q39375164	Effects of Insulin Plus Glucagon-Like Peptide-1 Receptor Agonists (GLP-1RAs) in Treating Type 1 Diabetes Mellitus: A Systematic Review and Meta-Analysis
Q37597010	Exenatide treatment for 6 months improves insulin sensitivity in adults with type 1 diabetes.
Q64271837	HNF1A gene p.I27L is associated with early-onset, maturity-onset diabetes of the young-like diabetes in Turkey
Q42759522	Hepatic Steatosis is Common in Adolescents with Obesity and PCOS and Relates to De Novo Lipogenesis but not Insulin Resistance
Q30583410	Heterogeneous behavior of lipids according to HbA1c levels undermines the plausibility of metabolic syndrome in type 1 diabetes: data from a nationwide multicenter survey.
Q37276007	Improvement in insulin sensitivity after human islet transplantation for type 1 diabetes.
Q36104684	Insulin Delivery Into the Peripheral Circulation: A Key Contributor to Hypoglycemia in Type 1 Diabetes
Q51249806	Insulin Resistance, Hyperinsulinemia, and Mitochondria Dysfunction in Nonobese Girls With Polycystic Ovarian Syndrome.
Q38642435	Insulin resistance, role of metformin and other non-insulin therapies in pediatric type 1 diabetes
Q27000205	Insulin sensitivity and complications in type 1 diabetes: New insights
Q34194600	Islet autoimmunity identifies a unique pattern of impaired pancreatic beta-cell function, markedly reduced pancreatic beta cell mass and insulin resistance in clinically diagnosed type 2 diabetes
Q36951888	Lipoprotein subfraction cholesterol distribution is more atherogenic in insulin resistant adolescents with type 1 diabetes
Q35531487	Longitudinal Analysis of Adiponectin through 20-Year Type 1 Diabetes Duration
Q33816920	Loss of Pgc-1α expression in aging mouse muscle potentiates glucose intolerance and systemic inflammation
Q64055922	Maternal genetic contribution to pre-pregnancy obesity, gestational weight gain, and gestational diabetes mellitus
Q42774876	Metabolomic Response of Skeletal Muscle to Aerobic Exercise Training in Insulin Resistant Type 1 Diabetic Rats
Q34336580	Metabolomics approach for analyzing the effects of exercise in subjects with type 1 diabetes mellitus.
Q92784064	Metformin Improves Peripheral Insulin Sensitivity in Youth With Type 1 Diabetes
Q36637876	Modeling changes in glucose and glycerol rates of appearance when true basal rates of appearance cannot be readily determined
Q41301765	Morphological assessment of pancreatic islet hormone content following aerobic exercise training in rats with poorly controlled Type 1 diabetes mellitus
Q98566249	Nonalcoholic fatty liver disease in obese adolescent females is associated with multi-tissue insulin resistance and visceral adiposity markers
Q39016504	Obese adolescents with polycystic ovarian syndrome have elevated cardiovascular disease risk markers
Q38176677	Old and new basal insulin formulations: understanding pharmacodynamics is still relevant in clinical practice
Q55420946	Oral Glucose Tolerance Test Glucose Peak Time Is Most Predictive of Prediabetes and Hepatic Steatosis in Obese Girls.
Q90429872	Pancreatic Islet Transplantation in Humans: Recent Progress and Future Directions
Q45408176	Prevalence and natural history of histologically proven chronic liver disease in a longitudinal cohort of patients with type 1 diabetes
Q46596220	Protein and fat meal content increase insulin requirement in children with type 1 diabetes - Role of duration of diabetes
Q64116042	Reduced hepatocellular lipid accumulation and energy metabolism in patients with long standing type 1 diabetes mellitus
Q37732357	Serum uric acid and insulin sensitivity in adolescents and adults with and without type 1 diabetes
Q49962054	Sex-specific differences in insulin resistance in type 1 diabetes: The CACTI cohort
Q36508961	The importance of palmitoleic acid to adipocyte insulin resistance and whole-body insulin sensitivity in type 1 diabetes
Q92863320	Urocortin 2 Gene Transfer Improves Glycemic Control and Reduces Retinopathy and Mortality in Murine Insulin Deficiency
Q48045198	Why should people with type 1 diabetes exercise regularly?
Q90312756	Youth With Type 1 Diabetes Have Adipose, Hepatic, and Peripheral Insulin Resistance
Q90613030	Youth with type 2 diabetes have hepatic, peripheral, and adipose insulin resistance